Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • ASTCT Town Hall - June 2021

    Contains 1 Component(s) Includes a Live Web Event on 06/30/2021 at 12:00 PM (EDT)

    Join us for an ASTCT Town Hall to hear updates from ASTCT President, Dr. Stella Davies, and ASTCT Director of Government Relations, Alycia Maloney, JD. This webinar is open to ASTCT Members only.

    Join us for an ASTCT Town Hall to hear updates from ASTCT President, Dr. Stella Davies, and ASTCT Director of Government Relations, Alycia Maloney, JD. This webinar is open to ASTCT Members only.

  • Clinical Advances in CAR T-Cell Therapy

    Contains 1 Component(s) Includes a Live Web Event on 06/29/2021 at 3:00 PM (EDT)

    Join us for the second in ASTCT's CAR-T Webinar Series on June 29, 2021 at 2 PM CT with our speaker, Dr. Frederick Locke, and our moderator, Dr. Akshay Sharma. This webinar, 'Clinical Advances in CAR T-Cell Therapy' will cover a review of approved CAR-T products, practical aspects of referrals, eligibility, leukapheresis, and more!

    Join us for the second in ASTCT's CAR-T Webinar Series on June 29, 2021 at 2 PM CT with our speaker, Dr. Frederick Locke, and our moderator, Dr. Akshay Sharma. This webinar, 'Clinical Advances in CAR T-Cell Therapy' will cover a review of approved CAR-T products, practical aspects of referrals, eligibility, leukapheresis, and more! If you have any questions you would like to submit for the Q&A with Dr. Locke, please email info@astct.org.

    Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.

  • CAR-T Basics & Biology Webinar

    Contains 2 Component(s)

    The first in ASTCT's new CAR-T Webinar Series aired on June 9, 2021 with our speaker, Dr. Marcela Maus, and our moderator, Dr. Armin Ghobadi. This webinar, 'CAR-T Basics and Biology' covered an overall review of CAR-T Biology, the general process of generating CAR-T, CAR-T targets, the future directions of CAR-T biology, and more!

    The first in ASTCT's new CAR-T Webinar Series aired on June 9, 2021 with our speaker, Dr. Marcela Maus, and our moderator, Dr. Armin Ghobadi. This webinar, 'CAR-T Basics and Biology' covered an overall review of CAR-T Biology, the general process of generating CAR-T, CAR-T targets, the future directions of CAR-T biology, and more!

    Thank you to Janssen Oncology and Legend Biotech for their generous support of this webinar series.

  • FY2022 IPPS Proposed Rule Webinar

    Contains 2 Component(s)

    Join ASTCT Director of Government Relations, Alycia Maloney, JD and Reimbursement and Policy Advisors to ASTCT from Nimitt Consulting, Jugna Shah and Amy Rinkle, for the FY2022 IPPS Proposed Rule webinar on June 8th, at 11 AM CT.

    Join ASTCT Director of Government Relations, Alycia Maloney, JD and Reimbursement and Policy Advisors to ASTCT from Nimitt Consulting, Jugna Shah and Amy Rinkle, for the FY2022 IPPS Proposed Rule webinar on June 8th, at 11 AM CT. Maloney, Shah, and Rinkle will cover:

    CAR-T:
    - Proposed payment policy for MS-DRG 018 for CAR-T
    - Change in MS-DRG naming and proposed mapping of new therapies into the MS-DRG
    - CMS’ proposal to use FY 2019 data for FY 2022 rate-setting
    - CAR-T MS-DRG relative weight
    - Understanding CMS’ payment logic for CAR-T clinical trial cases and expanded access cases
    - CAR-T ICD-10 coding updates
    - Looking to the future of reimbursement

    Stem Cell Transplant
    - Overall payment update
    - Allogeneic SCT –proposed rule changes for removing cell acquisition costs from the MS-DRG payment amount
    - Section 108 cost-based reimbursement and the proposed rule

    Additional key updates to be aware of
    Next steps/feedback/thoughts

    There will be a Q&A section at the end of the webinar, so be sure to register and submit any questions in advance that you would like answered during the webinar to info@astct.org. Please consider sharing this webinar with your network of doctors, administrators, providers, or any other colleagues that may be interested.

    In order to join the webinar, select the tab titled 'Webinar' and click 'Join' at the time of the webinar start. This webinar will be recorded, and the recording will be made available 24-48 hours on this page. If you are not able to attend the live webinar, you still can register for this product and check back for the recording.

  • CAR-T Slide Library – All Modules

    Contains 1 Component(s)

    This comprehensive slide library was developed by a group of clinicians that have been working together to create ongoing educational initiatives about CAR T therapy since 2017. The library covers several topics including: why CAR-T therapy, how CAR-T fits into the world of immuno-oncology, patient management, and institutional considerations. You have the option to download the full library, containing several modules, or you can download individual modules, as needed.

    This comprehensive slide library was developed by a group of clinicians that have been working together to create ongoing educational initiatives about CAR T therapy since 2017. The library covers several topics including: why CAR-T therapy, how CAR-T fits into the world of immuno-oncology, patient management, and institutional considerations. You have the option to download the full library, containing several modules, or you can download individual modules, as needed.

    THANK YOU TO THE FOLLOWING PHYSICIANS FOR THEIR WORK ON THIS INITIATIVE:

    Jesus G. Berdeja, MD, Sarah Cannon Research Institute
    Michael Bishop, MD, University of Chicago
    Ian Flinn, MD, PhD, Sarah Cannon Research Institute
    Ahmed Galal, MD, FRCPC, MSc, Duke University Medical Center
    Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center
    Brian Hill, MD, PhD, Cleveland Clinic
    Samantha Jaglowski, MD, MPH, Ohio State University
    Michael Jain, MD, PhD, Moffitt Cancer Center
    Krishna Komanduri, MD, University of Miami
    Yi Lin, MD, PhD, Mayo Clinic
    Matthew Lunning, DO, University of Nebraska Medical Center
    David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center
    David Miklos, MD, PhD, Stanford University
    Sara Nikiforow, MD, PhD, Dana-Farber Cancer Institute
    Jae Park, MD, Memorial Sloan Kettering Cancer Center
    David Porter, MD, University of Pennsylvania
    Ran Reshef, MD, Columbia University Medical Center
    Jason Westin, MD, MD Anderson Cancer Center

  • CAR-T Therapies: Acute Lymphoblastic Leukemia

    Contains 1 Component(s)

    This is the fourth module of the CAR-T Slide Deck. Acute Lymphoblastic Leukemia • Prognosis of relapsed adults with ALL • Overview of novel agents in R/R ALL, including anti-CD19 CAR T cell therapy • CAR T Therapy as a Bridge to Allogeneic Transplant?

    This is the fourth module of a comprehensive slide library developed by a group of clinicians that have been working together to create ongoing educational initiatives about CAR T therapy since 2017. The library covers several topics including: why CAR-T therapy, how CAR-T fits into the world of immuno-oncology, patient management, and institutional considerations. You have the option to download the full library, containing several modules, or you can download individual modules, as needed.

    This module covers the following topics:

    • Prognosis of relapsed adults with ALL
    • Overview of novel agents in R/R ALL, including anti-CD19 CAR T cell therapy
    • CAR T Therapy as a Bridge to Allogeneic Transplant?

  • ASTCT Pharmacy SIG Online Journal Club - May 2021

    Contains 1 Component(s)

    The Pharmacy SIG Online Journal Club session will be presented on May 19, 2021.

    The Pharmacy SIG Online Journal Club was presented live on May 19, 2021

    Presenters & Articles

    Jordyn Higgins, PharmD
    PGY-2 Oncology Pharmacy Resident
    Emory University Hospital Midtown/Winship Cancer Institute
    Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001):a multicentre seamless design study- Jordyn Higgins, PharmD (https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)31366-0.pdf)

    Jordanne Adolphsen, PharmD
    PGY-2 Oncology Pharmacy Resident
    The University of Kansas Health System
    Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma (https://www.nejm.org/doi/full/10.1056/NEJMoa2024850 )

    Session Learning Objectives:
    Upon completion of the activity, participants should be able to:

    1. Discuss recent BMT pharmacy studies and their applications to current practice.
    2. Evaluate the safety and efficacy of liso-cel for the treatment of large B-cell lymphomas (LBCL).
    3. Assess the efficacy and safety of ide-cel in patients with triple exposed relapsed and refractory myeloma and to evaluate the pharmacokinetics, immunogenicity, and potential biomarkers for response and progression.

    Information on CE, including disclosure information, can be found on the CE Information handout.

  • Why CAR-T Therapy

    Contains 1 Component(s)

    This is the first module of the CAR-T Slide Deck. Why CAR-T Therapy? • How the normal immune system functions • T-cell antitumor responses and mechanisms by which cancer cells escape immune surveillance

    This is the first module of a comprehensive slide library developed by a group of clinicians that have been working together to create ongoing educational initiatives about CAR T therapy since 2017. The library covers several topics including: why CAR-T therapy, how CAR-T fits into the world of immuno-oncology, patient management, and institutional considerations. You have the option to download the full library, containing several modules, or you can download individual modules, as needed.

    This module covers the following topics:

    • How the normal immune system functions
    • T-cell antitumor responses and mechanisms by which cancer cells escape immune surveillance

  • CAR-T in Immuno-Oncology

    Contains 1 Component(s)

    This is the second module of the CAR-T Slide Deck. How CAR-T Therapy Fits Into the World of Immuno-Oncology: • Timeline of immunotherapy • Allogeneic transplant, high-dose IL-2, and donor lymphocyte infusions • Monoclonal antibodies and vaccines: INF-α and anti-CD20–targeted therapies • Immune modulators and checkpoint inhibitors • How to optimally harness antitumor immunity: the role of CAR-T cells

    This is the second module of a comprehensive slide library developed by a group of clinicians that have been working together to create ongoing educational initiatives about CAR T therapy since 2017. The library covers several topics including: why CAR-T therapy, how CAR-T fits into the world of immuno-oncology, patient management, and institutional considerations. You have the option to download the full library, containing several modules, or you can download individual modules, as needed.

    This module covers the following topics:

    • Timeline of immunotherapy
    • Allogeneic transplant, high-dose IL-2, and donor lymphocyte infusions
    • Monoclonal antibodies and vaccines: INF-α and anti-CD20–targeted therapies
    • Immune modulators and checkpoint inhibitors
    • How to optimally harness antitumor immunity: the role of CAR T cells

  • How CAR-T Therapy Works

    Contains 1 Component(s)

    This is the third module of the CAR-T Slide Deck. How CAR-T Therapy Works: • CAR-T cells: mechanism of action • Chimeric antigen receptors (CARs) • Advantages of CAR-T therapy • Bispecific T-Cell Engager (BiTE) antibodies: the difference between CARs and BiTEs

    This is the third module of a comprehensive slide library developed by a group of clinicians that have been working together to create ongoing educational initiatives about CAR T therapy since 2017. The library covers several topics including: why CAR-T therapy, how CAR-T fits into the world of immuno-oncology, patient management, and institutional considerations. You have the option to download the full library, containing several modules, or you can download individual modules, as needed.

    This module covers the following topics:

    • CAR-T cells: mechanism of action
    • Chimeric antigen receptors (CARs)
    • Advantages of CAR-T therapy
    • Bispecific T-Cell Engager (BiTE) antibodies: the difference between CARs and BiTEs